RxDoctor Payments Data

Adam Powell, DO

Pain Medicine · Grand Rapids, MINPI 1134460439

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 270 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,140 and has fallen 77.0% since, to $262 in 2025.

$5,136in general payments, 2019–2025

Across 270 payments — averaging $19.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1K
  • Nevro Corp.$763
  • Teva Pharmaceuticals USA, Inc.$582
  • Boston Scientific$379
  • Collegium Pharmaceutical, Inc.$358
  • Biohaven Pharmaceutical Holding Company Ltd.$314
  • plus $2K from 26 others

What the payments were for

  • Food & beverage$5,136100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,136 in reported general payments places this provider in the 65th percentile of 139 pain medicine providers in Michigan.

See all pain medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$207,904
Medicare patients
226
Services billed
4,552

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,147$19,491
OxycontinOxycodone Hcl14$13,266
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen355$7,621
Fentanyl70$5,621
Gabapentin465$5,405
Pregabalin250$4,319
Morphine Sulfate ErMorphine Sulfate136$2,837
Tizanidine Hcl245$2,411
Oxycodone Hcl110$1,787
Diclofenac Sodium30$1,303
Methadone Hcl126$1,247
Morphine Sulfate58$1,185
Cyclobenzaprine Hcl177$1,005
Methocarbamol82$830
Tramadol Hcl190$810

Paid to pharmacies, not to this prescriber.

Other pain medicine in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →